drugset / Trial / NCT00601848

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

NCT00601848

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Photodynamic therapy uses a drug, such as porfimer sodium, that is absorbed by tumor cells. The drug becomes active when it is exposed to light. When the drug is active, tumor cells are killed. Giving photodynamic therapy during surgery may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial is studying the side effects and how well photodynamic therapy given during surgery works in treating patients with resectable non-small cell lung cancer that has spread to the pleura.

Timeline

Start
2004-11
Primary completion
2012-02
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject porfimer sodium Small molecule Intravenous